13 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Design, Syntheses, and Anti-TB Activity of 1,3-Benzothiazinone Azide and Click Chemistry Products Inspired by BTZ043.
University of Notre Dame
Discovery of N-(1-(6-Oxo-1,6-dihydropyrimidine)-pyrazole) Acetamide Derivatives as Novel Noncovalent DprE1 Inhibitors against Mycobacterium tuberculosis.
Zhejiang University
Benzothiozinone derivatives with anti-tubercular Activity-Further side chain investigation.
Suzhou Medical College of Soochow University
Targeting mycobacterial membranes and membrane proteins: Progress and limitations.
National Institute of Pharmaceutical Education and Research-Hyderabad
Identification of thiophene-benzenesulfonamide derivatives for the treatment of multidrug-resistant tuberculosis.
Peking Union Medical College and Chinese Academy of Medical Sciences
Exploring disordered loops in DprE1 provides a functional site to combat drug-resistance in Mycobacterium strains.
Northwest A&F University
Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents.
Soochow University
Discovery of Novel Thiophene-arylamide Derivatives as DprE1 Inhibitors with Potent Antimycobacterial Activities.
Peking Union Medical College and Chinese Academy of Medical Sciences
Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents.
Soochow University
Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents.
Soochow University
Optimization of Hydantoins as Potent Antimycobacterial Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) Inhibitors.
University of Antwerp